By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...
"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...
Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...
(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...
CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...
Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...
Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...
Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...
Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...
The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results